News
CYCN
3.200
+3.89%
0.120
Weekly Report: what happened at CYCN last week (0318-0322)?
Weekly Report · 4d ago
Weekly Report: what happened at CYCN last week (0311-0315)?
Weekly Report · 03/18 11:57
Weekly Report: what happened at CYCN last week (0304-0308)?
Weekly Report · 03/11 11:52
Weekly Report: what happened at CYCN last week (0226-0301)?
Weekly Report · 03/04 11:56
Weekly Report: what happened at CYCN last week (0219-0223)?
Weekly Report · 02/26 12:13
Weekly Report: what happened at CYCN last week (0212-0216)?
Weekly Report · 02/19 12:16
Weekly Report: what happened at CYCN last week (0205-0209)?
Weekly Report · 02/12 12:02
12 Health Care Stocks Moving In Tuesday's Intraday Session
InVivo Therapeutics Hldg (NASDAQ:NVIV) stock rose 306.0% to $0.9 during Tuesday's regular session. The company's market cap increased to $2.7 million. Cyclerion Therapeutic stock rose 56.02% and Immunome stock increased by 26.06% in the same session. Losers include BioRestorative Therapies and Akso Health Group.
Benzinga · 02/06 17:31
Weekly Report: what happened at CYCN last week (0129-0202)?
Weekly Report · 02/05 12:14
Weekly Report: what happened at CYCN last week (0122-0126)?
Weekly Report · 01/29 11:58
Cyclerion Therapeutics Inc: Statement of changes in beneficial ownership of securities
Press release · 01/26 22:20
Cyclerion Therapeutics Inc: [Amend]Statement of acquisition of beneficial ownership by individuals
Press release · 01/22 22:10
Weekly Report: what happened at CYCN last week (0115-0119)?
Weekly Report · 01/22 12:04
Weekly Report: what happened at CYCN last week (0108-0112)?
Weekly Report · 01/15 11:58
12 Health Care Stocks Moving In Thursday's Intraday Session
Atreca (NASDAQ:BCEL) shares increased by 102.7% to $0.22 during Thursday's regular session. Sagimet Biosciences stock rose 36.13% in the regular session to $7.12. Cyclerion Therapeutics and Sera Prognostics also gained. Losers include 180 Life Sciences and 180 Pharmaceuticals.
Benzinga · 01/11 17:31
Weekly Report: what happened at CYCN last week (0101-0105)?
Weekly Report · 01/08 12:04
Weekly Report: what happened at CYCN last week (1225-1229)?
Weekly Report · 01/01 11:56
Weekly Report: what happened at CYCN last week (1218-1222)?
Weekly Report · 12/25/2023 12:12
Weekly Report: what happened at CYCN last week (1211-1215)?
Weekly Report · 12/18/2023 12:20
More
Webull provides a variety of real-time CYCN stock news. You can receive the latest news about Cyclerion Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About CYCN
Cyclerion Therapeutics, Inc. is a biopharmaceutical company. Its portfolio includes novel soluble guanylate cyclase (sGC) stimulators that modulate a key node in a fundamental signaling network in both the central nervous system (CNS) and the periphery. Zagociguat is a clinical-stage CNS-penetrant sGC stimulator that has shown rapid improvement in cerebral blood flow, functional brain connectivity, brain response to visual stimulus, cognitive performance, and biomarkers associated mitochondrial function and inflammation in clinical studies. CY 3018 is a CNS-targeted sGC stimulator that preferentially localizes to the brain and has a pharmacology profile that suggests its potential for the treatment of neuropsychiatric diseases and disorders. Praliciguat is a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. and being advanced in rare kidney disease. Olinciguat is a vascular sGC stimulator that the Company intends to out-license for cardiovascular diseases.